Skip to main content
SpringerLink
Log in

15-Deoxyspergualin (15-DOS) for therapy in an animal model of multiple sclerosis (MS): Disease modifying activity on acute and chronic relapsing experimental allergic encephalomyelitis (EAE)

  • Autoimmunity
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

We examined the therapeutic effect of 15-DOS in the two models of acute and chronic relapsing EAE in Lewis rats. In the first model adult rats developed an acute severe EAE and by day 16 all animals died. Lewis rats treated with 15-DOS showed a delayed and reduced onset of clinical symptoms and mortality was prevented. In the second model Lewis rats (aged animals) developed a chronic relapsing EAE with up to three relapses. The second and third episodes were both milder and shorter in duration. All animals treated with 15-DOS survived the delayed first attack and developed no further relapses.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. R. H. Laatsch, M. W. Kies, S. Gordon and E. C. Alvord,The encephalitogenic activity of myelin isolated by ultracentrifugation. J. Exp. Med115, 777–792 (1962).

    Article  Google Scholar 

  2. S. Levine,Relationship of experimental allergic encephalomyelitis to human disease. Res. Pub. Assoc. Res. Nerv. Ment. Dis.49, 33–38 (1971).

    Google Scholar 

  3. H. L. Weiner, A. K. Bhan, J. Burks, F. Gilles, C. Kerr, E. Reniherz and S. L. Hanser,Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions. Neurology34 (Suppl.) 112–115 (1984).

    Google Scholar 

  4. C. Feurer, D. E. Prentice, and S. Cammisuli,Chronic relapsing experimental allergic encephalomyelitis in the Lewis rat. J. Neuroimmunol.10, 159–166 (1985).

    Article  PubMed  Google Scholar 

  5. Y. Umeda,Synthesis and antitumor activity of spergualin analogues. III. Novel method for synthesis of optically active 15-deoxy-11-O-methylspergualin. J. Antibiot.40, 1316–1322 (1987).

    PubMed  Google Scholar 

  6. H. U. Schorlemmer, G. Dickneite, and F. R. Seiler,Treatment of acute rejection episodes and induction of tolerance in rat skin allotransplantation by 15-Deoxyspergualin. Transplant. Proc.22, 1626–1630 (1990).

    PubMed  Google Scholar 

  7. H. U. Schorlemmer, R. R. Bartlett, R. Schleyerbach, G. Dickneite and F. R. Seiler,Immunosuppressive therapy of experimental autoimmune disease like rheumatoid arthritis and systemic lupus erythematosus by 15-Deoxyspergualin. Int. J. Immunotherapy5, 9–20 (1989).

    Google Scholar 

  8. H. U. Schorlemmer, R. R. Bartlett, R. Schleyerbach, G. Dickneite, and F. R. Seiler,Disease modifying activity of 15-Deoxyspergualin (15-DOS) on the development of systemic lupus erythematosus (SLE) and adjuvant arthritis. InRecent Advances in Chemotherapy (Eds. E. Rubinstein and D. Adam) pp. 8621–8622 E. Lewin-Epstein Ltd. Offset Printers, Jerusalem, Israel, (1989).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research Laboratories of Behringwerke AG, P.O. Box 1140, D-3350, Marburg/Lahn, FRG

    H. U. Schorlemmer & F. R. Seiler

Authors
  1. H. U. Schorlemmer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. R. Seiler
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schorlemmer, H.U., Seiler, F.R. 15-Deoxyspergualin (15-DOS) for therapy in an animal model of multiple sclerosis (MS): Disease modifying activity on acute and chronic relapsing experimental allergic encephalomyelitis (EAE). Agents and Actions 34, 156–160 (1991). https://doi.org/10.1007/BF01993265

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01993265

Keywords

Search

Navigation